Adhera Therapeutics, Inc. ATRX
We take great care to ensure that the data presented and summarized in this overview for Adhera Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ATRX
Top Purchases
Top Sells
About ATRX
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Insider Transactions at ATRX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 26
2011
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
74,500
-0.21%
|
$74,500
$1.15 P/Share
|
|
Jan 25
2011
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
93,005
-0.3%
|
$93,005
$1.14 P/Share
|
|
Jan 24
2011
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
72,800
-0.24%
|
$72,800
$1.19 P/Share
|
|
Jan 21
2011
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
69,500
-0.31%
|
$69,500
$1.27 P/Share
|
|
Jan 20
2011
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
51,400
-0.08%
|
$51,400
$1.35 P/Share
|
|
Jan 19
2011
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
42,800
-0.14%
|
$42,800
$1.54 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders